Analytical sensors that can detect chemical (including biological) analytes are becoming increasingly widespread within the field of analytical chemistry. More than this, in a world tending towards the 'internet-of-things', the miniaturization of such devices is becoming increasingly urgent. Accordingly, electrochemical methods that are simultaneously multiplexable and effective at a miniature scale are receiving much attention. In the present work, we compare the label-free electrochemical response of enzymatic biosensors with the response of their optical counterpart. As a proof-of-concept we compare the electrochemical impedimetric response and the first time described capacitive response of enzymatic biosensors to their optical reflectance response (measured in the visible region using a portable handset spectrophotometer). The target was the detection of glucose and urea. The chemical platform of the sensors was composed of enzymatically functionalized polyaniline thin films. Sensitivity, linearity, and the limit of detection were analyzed for both electrochemical and optical instrumental settings. We found that the impedimetric/capacitive electrochemical setup produced a response that was of a similar quality to the optical response (sensitivities of 10.7 ± 0.7, 7.4 ± 0.7 and 4.3 ± 0.2% per decade for impedimetric, capacitive and optical glucose biosensors, respectively) with a broader linear range (10 to 10 mol L for both glucose and urea biosensors) and similar limit-of-detection in the range of 1 μmol L within a relevant and practical diagnosis range for biomedical applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d0ay01018a | DOI Listing |
Vet Anim Sci
March 2025
Animal Science Research Department, Fars Agricultural and Natural Resources Research and Education Center, Agricultural Research, Education and Extension Organization (AREEO), Shiraz, Iran.
This study aims to measure the effects of different dietary concentrations of triticale hay (TH) on productive performance, carcass characteristics, microbial protein synthesis (MPS), ruminal and blood variables, and antioxidant power in 40 fattening male Gray Shirazi lambs (BW of 33.2 ± 1.1 kg) over 81 days in a completely randomized design (10 animals/diet).
View Article and Find Full Text PDFTrop Anim Health Prod
January 2025
Animal Science Department, Federal University of Paraná, Palotina, PR, 85950-000, Brazil.
This study aimed to evaluate the effect of autolyzed yeast (obtained from culture of Saccharomyces cerevisiae in sugarcane derivatives) supplementation on diet digestibility, feeding behavior, levels of blood metabolites associated with protein and energy metabolism, and performance of Dorper × Santa Ines lambs finished in feedlot. Twenty-four non-castrated male lambs with an average age of 4 months and a body weight (BW) of 19.49 ± 3.
View Article and Find Full Text PDFJ Ethnopharmacol
January 2025
School of Integrative Medicine, Nanjing University of Chinese Medicine, Jiangsu, Nanjing 210023. Electronic address:
Ethnopharmacological Relevance: Danggui Buxue Decoction (DBD) is a classic traditional Chinese herbal formulation, composed of Astragali Radix (AR) and Angelica Sinensis Radix (ASR) in a ratio of 5:1. It is a traditional Chinese medicine classic prescription for nourishing Qi and Yin (vital energy and body fluids), and it is effective in treating various clinical diseases. Diabetic nephropathy (DN) is categorized under "thirsting," "edema," and "turbid urine" in Traditional Chinese Medicine (TCM).
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
January 2025
The State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China. Electronic address:
Ela tablets (ALP) is a traditional Uyghur medicinal formulation comprising 9 herbs. Clinical applications have demonstrated its potential in treating diabetic nephropathy (DN). However, its specific medicinal effects and pharmacodynamic components have not been elucidated.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Background: This study evaluates the efficacy and safety of sitagliptin versus gliclazide, combined with metformin, in treatment-naive patients with type 2 diabetes mellitus (T2DM) and glucotoxicity.
Methods: In this single-center, randomized, controlled noninferiority trial, 129 treatment-naive patients with T2DM with glucotoxicity (fasting plasma glucose [FPG] ≥ 200 mg/dL and glycated hemoglobin ≥ 9.0%) were randomized to receive sitagliptin plus metformin (n = 66) or gliclazide plus metformin (n = 63) for 12 weeks.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!